652 related articles for article (PubMed ID: 19453349)
21. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
[TBL] [Abstract][Full Text] [Related]
22. Skin protectant drug products for over-the-counter human use; final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Jun; 68(107):33362-81. PubMed ID: 12785379
[TBL] [Abstract][Full Text] [Related]
23. Advances in dermatopharmacology--strength and weakness of recently of approved drugs (I).
Chang YC; Maibach HI
Int J Clin Pharmacol Ther; 1997 May; 35(5):188-94. PubMed ID: 9174873
[No Abstract] [Full Text] [Related]
24. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Dec; 68(250):75414-8. PubMed ID: 14986677
[TBL] [Abstract][Full Text] [Related]
25. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
[TBL] [Abstract][Full Text] [Related]
26. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
[TBL] [Abstract][Full Text] [Related]
27. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
[TBL] [Abstract][Full Text] [Related]
28. Leavitt: reforms will improve oversight and openness at FDA.
FDA Consum; 2005; 39(3):37. PubMed ID: 16127819
[TBL] [Abstract][Full Text] [Related]
29. Safety-related drug labeling changes approved by FDA.
White GG
J Toxicol Clin Toxicol; 1998; 36(3):265-7. PubMed ID: 9678979
[No Abstract] [Full Text] [Related]
30. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691
[TBL] [Abstract][Full Text] [Related]
31. FDA policy on unapproved drug products: past, present, and future.
Chhabra R; Kremzner ME; Kiliany BJ
Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239
[TBL] [Abstract][Full Text] [Related]
32. FDA electronic drug labels to improve patient safety.
J Pain Palliat Care Pharmacother; 2006; 20(2):96-7. PubMed ID: 16789334
[No Abstract] [Full Text] [Related]
33. Drug therapy in pediatrics: a developing field.
Mathis L; Rodriguez W
Dermatol Ther; 2009; 22(3):257-61. PubMed ID: 19453350
[TBL] [Abstract][Full Text] [Related]
34. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
[TBL] [Abstract][Full Text] [Related]
35. The role of epidemiology in the regulation of oral contraceptives.
Sobel S
Public Health Rep; 1984; 99(4):350-4. PubMed ID: 6431481
[TBL] [Abstract][Full Text] [Related]
36. Black box warnings: what do they mean to pharmacists and patients.
Martin CM; Borgelt L
Consult Pharm; 2012 Jul; 27(7):482-92. PubMed ID: 22910129
[TBL] [Abstract][Full Text] [Related]
37. Drug treatments for skin disease introduced in 2006.
Skin Therapy Lett; 2007 May; 12(4):4-7. PubMed ID: 17551663
[TBL] [Abstract][Full Text] [Related]
38. Consumer understanding of prescription drug information: an illustration using an antidepressant medication.
Shiffman S; Gerlach KK; Sembower MA; Rohay JM
Ann Pharmacother; 2011 Apr; 45(4):452-8. PubMed ID: 21427296
[TBL] [Abstract][Full Text] [Related]
39. The FDA announces new prescription drug information format.
FDA Consum; 2006; 40(2):25-7. PubMed ID: 16671197
[TBL] [Abstract][Full Text] [Related]
40. The Value of the Black Box Warning in Dermatology.
Winterfield L; Vleugels RA; Park KK
J Drugs Dermatol; 2015 Jul; 14(7):660-6. PubMed ID: 26151780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
